Studies related to Blood Flow and Curcumin

Potential Role Of Curcumin Phytosome (Meriva) In Controlling The Evolution Of Diabetic Microangiopathy. A Pilot Study

Effect Increase
Trial Design Double blind
Trial Length n/a
Number of Subjects 25
Sex n/a
Notes for this study:
1g of curcumin (Meriva; enhanced bioavailability) was taken in two divided dosages of 500mg in 25 diabetic patients without insulin therapy; an improvement in microangiopathic symptoms was seen as well as a reduction in edema associated with diabetes over a period of 4 weeks.

Microangiopathy recorded as 'blood flow', although only specific to small vessels.

Full details on all 5 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.